| Objective/purpose: |
Collect supportive and pivotal data needed to establish the effectiveness of sGnRHa/Ovaplant® to induce gamete maturation in a variety of fish species. |
| Drug name: |
Ovaplant®; Salmon Gonadotropin - Releasing Hormone analogue
[Des-Gly10, D-Arg6, Trp7, Leu8] - LHRH, ethyl amide) |
| Source of drug: |
Western
Chemical, Inc. |
| Address: |
1269 Lattimore Road
Ferndale, WA 98248 USA |
| Contact: |
Attention: Jim Brackett
Toll Free: 800-283-5292
Tel: 360-384-5898
email: brackett@wchemical.com
webpage: http://www.syndel.com/ |
| Target
pathogen(s): |
Not Applicable |
| Method
of administration: |
Pellet-implant treatment |
| Treatment
dosage: |
10 - 75 micrograms sGnRHa per kilogram body weight |
| Treatment
regimen: |
Implant: Single treatment |
| Withdrawal
period: |
Implant: No Release. All treated broodfish must be maintained indefinitely or destroyed. |
| Required
test parameters: |
Investigator must collect data reporting percent ovulation and/or percent spermiation in treated fish. Investigator should also report general fish behavior and any adverse effects relating to treatment.
|
| Limitations
or restrictions on use: |
Investigator must follow all instructions in the Study Protocol for INAD 11-375 regarding drug acquisition and handling, fish treatment and disposition, and data reporting requirements.
Drug discharge must be in compliance with local NPDES permitting requirements. |
| Required
INAD fee: |
$400.00
per facility per year |
| AADAP
contact for other information: |
Ms.
Bonnie Johnson, FWS - AADAP
Phone: 406-994-9905
Fax: 406-582-0242
bonnie_johnson@fws.gov |
| Disclaimer: |
Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government. |
|
